$69.39
+0.79
(+1.15%)▲
CVS Health Corp is a healthcare company that operates a retail pharmacy chain and provides a range of healthcare services and products.
0.73%
Downside
Day's Volatility :0.96%
Upside
0.22%
8.5%
Downside
52 Weeks Volatility :23.04%
Upside
15.89%
Period | Cvs Health Corporation | |
---|---|---|
3 Months | -6.31% | |
6 Months | -2.85% | |
1 Year | -7.56% | |
3 Years | -9.44% |
Market Capitalization | 87.0B |
Book Value | $59.36 |
Dividend Share | 2.42 |
Dividend Yield | 3.85% |
Earnings Per Share (EPS) | 6.47 |
PE Ratio | 10.67 |
PEG Ratio | 1.0 |
Wall Street Target Price | 86.76 |
Profit Margin | 2.34% |
Operating Margin TTM | 3.68% |
Return On Assets TTM | 3.68% |
Return On Equity TTM | 11.28% |
Revenue TTM | 356.6B |
Revenue Per Share TTM | 277.53 |
Quarterly Revenue Growth YOY | 12.0% |
Gross Profit TTM | 53.5B |
EBITDA | 18.4B |
Diluted Eps TTM | 6.47 |
Quarterly Earnings Growth YOY | -0.1 |
EPS Estimate Current Year | 8.3 |
EPS Estimate Next Year | 9.17 |
EPS Estimate Current Quarter | 1.85 |
EPS Estimate Next Quarter | 1.87 |
What analysts predicted
Upside of 25.03%
FY18 | Y/Y Change | |
---|---|---|
Revenue | 194.6B | ↑ 5.31% |
Net Income | -594.0M | ↓ 108.97% |
Net Profit Margin | -0.31% | ↓ 3.89% |
FY19 | Y/Y Change | |
---|---|---|
Revenue | 256.8B | ↑ 31.96% |
Net Income | 6.6B | ↓ 1216.84% |
Net Profit Margin | 2.58% | ↑ 2.89% |
FY20 | Y/Y Change | |
---|---|---|
Revenue | 268.7B | ↑ 4.65% |
Net Income | 7.2B | ↑ 8.22% |
Net Profit Margin | 2.67% | ↑ 0.09% |
FY21 | Y/Y Change | |
---|---|---|
Revenue | 292.1B | ↑ 8.71% |
Net Income | 8.0B | ↑ 11.45% |
Net Profit Margin | 2.74% | ↑ 0.07% |
FY22 | Y/Y Change | |
---|---|---|
Revenue | 322.5B | ↑ 10.39% |
Net Income | 4.3B | ↓ 46.12% |
Net Profit Margin | 1.34% | ↓ 1.4% |
FY23 | Y/Y Change | |
---|---|---|
Revenue | 357.8B | ↑ 10.95% |
Net Income | 8.3B | ↑ 93.55% |
Net Profit Margin | 2.33% | ↑ 0.99% |
Q3 FY22 | Q/Q Change | |
---|---|---|
Revenue | 81.2B | ↑ 0.65% |
Net Income | -3.4B | ↓ 215.52% |
Net Profit Margin | -4.2% | ↓ 7.86% |
Q4 FY22 | Q/Q Change | |
---|---|---|
Revenue | 83.8B | ↑ 3.31% |
Net Income | 2.3B | ↓ 167.53% |
Net Profit Margin | 2.75% | ↑ 6.95% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Revenue | 85.3B | ↑ 1.71% |
Net Income | 2.1B | ↓ 7.21% |
Net Profit Margin | 2.5% | ↓ 0.25% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Revenue | 88.9B | ↑ 4.27% |
Net Income | 1.9B | ↓ 11.0% |
Net Profit Margin | 2.14% | ↓ 0.36% |
Q3 FY23 | Q/Q Change | |
---|---|---|
Revenue | 89.8B | ↑ 0.95% |
Net Income | 2.3B | ↑ 18.94% |
Net Profit Margin | 2.52% | ↑ 0.38% |
Q4 FY23 | Q/Q Change | |
---|---|---|
Revenue | 93.8B | ↑ 4.51% |
Net Income | 2.0B | ↓ 9.51% |
Net Profit Margin | 2.18% | ↓ 0.34% |
FY18 | Y/Y Change | |
---|---|---|
Total Assets | 196.5B | ↑ 106.51% |
Total Liabilities | 137.9B | ↑ 140.12% |
FY19 | Y/Y Change | |
---|---|---|
Total Assets | 222.4B | ↑ 13.23% |
Total Liabilities | 158.3B | ↑ 14.77% |
FY20 | Y/Y Change | |
---|---|---|
Total Assets | 230.7B | ↑ 3.72% |
Total Liabilities | 161.0B | ↑ 1.73% |
FY21 | Y/Y Change | |
---|---|---|
Total Assets | 233.0B | ↑ 0.99% |
Total Liabilities | 157.6B | ↓ 2.11% |
FY22 | Y/Y Change | |
---|---|---|
Total Assets | 228.3B | ↓ 2.03% |
Total Liabilities | 157.0B | ↓ 0.42% |
FY23 | Y/Y Change | |
---|---|---|
Total Assets | 249.7B | ↑ 9.4% |
Total Liabilities | 173.1B | ↑ 10.28% |
Q3 FY22 | Q/Q Change | |
---|---|---|
Total Assets | 231.2B | ↑ 0.41% |
Total Liabilities | 160.2B | ↑ 3.51% |
Q4 FY22 | Q/Q Change | |
---|---|---|
Total Assets | 228.3B | ↓ 1.27% |
Total Liabilities | 157.0B | ↓ 2.02% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 239.3B | ↑ 4.84% |
Total Liabilities | 167.8B | ↑ 6.87% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 250.1B | ↑ 4.49% |
Total Liabilities | 177.1B | ↑ 5.56% |
Q3 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 251.3B | ↑ 0.49% |
Total Liabilities | 176.8B | ↓ 0.15% |
Q4 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 249.7B | ↓ 0.63% |
Total Liabilities | 173.1B | ↓ 2.1% |
FY18 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 8.9B | ↑ 10.72% |
Investing Cash Flow | -43.3B | ↑ 1376.3% |
Financing Cash Flow | 36.8B | ↓ 645.39% |
FY19 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 12.8B | ↑ 44.93% |
Investing Cash Flow | -3.3B | ↓ 92.29% |
Financing Cash Flow | -7.9B | ↓ 121.32% |
FY20 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 15.9B | ↑ 23.48% |
Investing Cash Flow | -5.5B | ↑ 65.74% |
Financing Cash Flow | -8.2B | ↑ 3.89% |
FY21 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 18.3B | ↑ 15.13% |
Investing Cash Flow | -5.3B | ↓ 4.93% |
Financing Cash Flow | -11.4B | ↑ 39.25% |
FY22 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 16.2B | ↓ 11.43% |
Investing Cash Flow | -5.0B | ↓ 4.07% |
Financing Cash Flow | -10.5B | ↓ 7.4% |
Q3 FY22 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 9.1B | ↑ 67.61% |
Investing Cash Flow | -4.9B | ↑ 131.36% |
Financing Cash Flow | -3.2B | ↑ 30.76% |
Q4 FY22 | Q/Q Change | |
---|---|---|
Operating Cash Flow | -2.0B | ↓ 121.4% |
Investing Cash Flow | -119.0M | ↓ 97.59% |
Financing Cash Flow | -2.2B | ↓ 32.04% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 7.4B | ↓ 481.05% |
Investing Cash Flow | -8.5B | ↑ 7054.62% |
Financing Cash Flow | 2.7B | ↓ 224.65% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 5.9B | ↓ 20.57% |
Investing Cash Flow | -10.4B | ↑ 21.71% |
Financing Cash Flow | 3.6B | ↑ 33.02% |
Q3 FY23 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 2.7B | ↓ 54.03% |
Investing Cash Flow | -19.6B | ↑ 89.61% |
Financing Cash Flow | -2.7B | ↓ 174.38% |
Sell
Neutral
Buy
Cvs Health Corporation is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.
Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
---|---|---|---|---|---|
Cvs Health Corporation | -11.56% | -2.85% | -7.56% | -9.44% | 30.84% |
The Cigna Corp | -1.86% | 11.58% | 35.13% | 37.07% | 133.85% |
Centene Corp. | -6.52% | -1.34% | 4.45% | 10.13% | 49.38% |
Unitedhealth Group Incorporated | -1.65% | -10.65% | -5.05% | 22.87% | 116.0% |
Elevance Health, Inc | -0.46% | 9.86% | 11.29% | 34.06% | 108.59% |
Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
---|---|---|---|---|---|---|---|---|
Cvs Health Corporation | 10.67 | 10.67 | 1.0 | 8.3 | 0.11 | 0.04 | 0.04 | 59.36 |
The Cigna Corp | 19.96 | 19.96 | 0.89 | 28.43 | 0.12 | 0.04 | 0.02 | 158.03 |
Centene Corp. | 14.69 | 14.69 | 0.68 | 6.77 | 0.11 | 0.04 | NA | 48.35 |
Unitedhealth Group Incorporated | 19.64 | 19.64 | 1.24 | 27.51 | 0.17 | 0.07 | 0.02 | 100.18 |
Elevance Health, Inc | 20.12 | 20.12 | 1.14 | 37.16 | 0.16 | 0.06 | 0.01 | 168.64 |
Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
---|---|---|---|---|---|
Cvs Health Corporation | Buy | $87.0B | 30.84% | 10.67 | 2.34% |
The Cigna Corp | Buy | $98.4B | 133.85% | 19.96 | 2.65% |
Centene Corp. | Buy | $38.9B | 49.38% | 14.69 | 1.91% |
Unitedhealth Group Incorporated | Buy | $432.3B | 116.0% | 19.64 | 4.05% |
Elevance Health, Inc | Buy | $117.9B | 108.59% | 20.12 | 3.49% |
Vanguard Group Inc
BlackRock Inc
State Street Corporation
Capital World Investors
FMR Inc
Capital Research & Mgmt Co - Division 3
In the quarter ending March,2024. Cvs Health Corporation has declared dividend of $0.67
Read MoreCVS Health Corporation is an American healthcare company that owns CVS Pharmacy, a retail pharmacy chain; CVS Caremark, a pharmacy benefits manager; and Aetna, a health insurance provider, among many other brands.
Organization | Cvs Health Corporation |
Employees | 219000 |
CEO | Ms. Karen Sue Lynch |
Industry | Retail Trade |